Back to Search
Start Over
BOOST: a phase 3 trial of sorafenib vs. best supportive care in first line treatment of hepatocellular carcinoma in patients with deteriorated liver function
- Source :
- Hepatoma Research.
- Publication Year :
- 2021
- Publisher :
- OAE Publishing Inc., 2021.
Details
- Database :
- OpenAIRE
- Journal :
- Hepatoma Research
- Accession number :
- edsair.doi.dedup.....bd7a3e38c25222261029a25b57fd0c3e
- Full Text :
- https://doi.org/10.20517/2394-5079.2021.58